The trauma and extremities devices market is projected to grow from US$ 13.43 billion in 2023 to US$ 17.72 billion by 2031; the market is estimated to record a CAGR of 6.2% during 2023-2031.

Key factors driving the market growth are rising number of road accidents and increasing cases of bone degenerative disorders in elderly population. However, the availability of alternative treatment alternatives and high cost of trauma extremity devices hinder the market growth. Furthermore, Increasing use of non-metallic fixators and bioabsorbable fixators is expected to bring new trauma and extremities devices market trends in the coming years.

Market Drivers and opportunities of the Trauma And Extremities Devices Market

According to the World Health Organization (WHO), road traffic crashes result in the death of approximately 1.19 million people every year, and between 20 and 50 million people are suffer from non-fatal injuries that hamper their daily life. On similar lines, the Indian Ministry of Road Transport and Highways (MORTH) and the National Crime Records Bureau (NCRB) provide the estimates of road crashes based on police data. As per the report, nearly 371,884 non-fatal road traffic injuries were reported in 2021, although the figure mentioned may be underestimated. Thus, the growing number of road traffic accidents that result in bone deformities escalate the demand for trauma and extremities devices.

However, the availability of alternative treatment alternatives and high cost of trauma extremity devices hinder the market growth.

Increasing Cases of Bone Degenerative Disorders in Elderly Population to Favor Market

Elderly people are at a greater risk of falls, and minor accidents can cause fractures or bone breakage due to the tendency of muscles and bones to wear off with age. Osteoporosis and other conditions that affect older people may further raise the risk of bone breakage. Thus, an upsurge in the elderly population is correlated with the soaring number of orthopedic injuries and disorders, which creates the demand for trauma and extremities devices. According to the Osteoarthritis (OA) Action Alliance, 88% of people with OA are at least 45 years old, and 43% are 65 or older in the US. Thus, the growing number of road traffic accidents escalates the demand for trauma and extremities devices.

Increasing Funding for Trauma Treatment - An Opportunity

In July 2021, the Substance Abuse and Mental Health Services Administration contributed US$ 62.4 million in grant funding to provide and increase access to effective treatment and service systems across the US. These funds aim to help children, adolescents, and their families who have experienced traumatic events. The White House will also provide additional support through US$ 800,000 in American Rescue Plan (ARP) funding. Thus, increasing funding for trauma treatment is likely to create significant opportunities in the trauma and extremities devices market.

Trauma And Extremities Devices Market: Segmental Overview

Key segments that contributed to the derivation of the trauma and extremities devices market analysis are device type and end user.

Based on device type, the trauma and extremities devices market is segmented into internal fixation devices, external fixation devices, craniofacial devices, long bone stimulation, and others. The internal fixation devices segment held the largest market share in 2023.

By end user, the market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2023.

Trauma And Extremities Devices Market: Geographical Overview

The scope of the global brachytherapy devices market report entails North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America held a major trauma and extremities devices market share in 2023, followed by Europe; the market in Asia Pacific region is growing with the highest CAGR during the forecast period. The growth of the trauma and extremities devices market in this region is attributed to the rising incidence of aortic aneurysm and its risk factors in the region.

North America dominated the trauma and extremities devices market. According to Centers for Disease Control and Prevention estimates, 21.2% of adults in the US, or 53.2 million people, had doctor-diagnosed arthritis from 2019 to 2021. Due to rising incidences of bone degenerative disorders in the region, North America held the largest share of the market in 2022. An inclination toward the development of technologically advanced products and the presence of global market players are factors contributing to the dominance of North America in the trauma and extremities devices market.

Trauma and Extremities Devices Market News and Recent Developments

The trauma and extremities devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments and strategies in the market for trauma and extremities devices:

Stryker launched its Gamma4 Hip Fracture Nailing System in most European markets. This newest Gamma system is designed to provide surgeons with the next generation of Stryker's intramedullary nailing system, and it is specifically designed to treat hip and femur fractures. The Gamma4 system aims to streamline procedural workflows for surgeons. In September 2023, the system received CE certification in Europe. (Source: Stryker, Press Release, 2023)

DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, launched the UNIUM System as the newest addition to its Power Tools portfolio. The system is designed with a commitment to ergonomics, reliability, and efficiency in the trauma setting. It can be used across small bone, sports medicine, spine, and thorax procedures. (Source: Johnson & Johnson, Press Release, 2021)